GFM
COLL icon

GF Fund Management’s Collegium Pharmaceutical COLL Stock Holding History

GF Fund Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.4K Sell
675
-36
-5% -$1.23K ﹤0.01% 467
2026
Q1 		$23.5K Buy
711
+91
+15% +$3.85K ﹤0.01% 485
2025
Q4 		$28.7K Sell
620
-58
-9% -$2.43K ﹤0.01% 468
2025
Q3 		$23.7K Sell
678
-148
-18% -$5.14K ﹤0.01% 472
2025
Q2 		$24.4K Hold
826
– – ﹤0.01% 482
2025
Q1 		$24.7K Buy
826
+149
+22% +$4.55K ﹤0.01% 478
2024
Q4 		$19.4K Buy
+677
New +$22.4K ﹤0.01% 473

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

GF Fund Management's COLL Position: Q2 2026 in Review

GF Fund Management reduced its Collegium Pharmaceutical (COLL) stake by 5.1% in Q2 2026, selling an estimated $1.23K and leaving 675 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #467.

GF Fund Management first reported a position in COLL in Q4 2024 and has held it in 7 quarters since. The position peaked at $28.7K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • GF Fund Management held 675 shares of Collegium Pharmaceutical worth $24.4K as of Q2 2026.
  • GF Fund Management sold 36 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.23K.
  • Collegium Pharmaceutical made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #467 holding.
  • GF Fund Management first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Collegium Pharmaceutical position peaked at $28.7K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.